TBIO Stock Ownership Activity

TRANSLATE BIO INC 13F holders

No value investing guru has made any change to the TRANSLATE BIO INC (TBIO) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying TBIO now?

According to the latest SEC filing(s) TRANSLATE BIO INC (TBIO) has not been purchased by any super investor.

To see more about who is investing in TRANSLATE BIO INC (TBIO), please go to the TBIO ownership page.

2021 Q3 (1 result)
Seth Klarman
-100.00%
-711,745
-4.55%
0.00%
Current price: $0.91 99.82% Reported price*: $492.29
2020 Q2 (1 result)
Seth Klarman
+2.85%
+27,778
+0.11%
4.00%
Current price: $0.91 99.71% Reported price*: $318.34
2019 Q3 (1 result)
Seth Klarman
+98.37%
+328,666
+1.00%
1.38%
Current price: $0.91 99.49% Reported price*: $176.70
2019 Q2 (1 result)
Seth Klarman
+36.25%
+130,719
+0.27%
1.02%
Current price: $0.91 99.59% Reported price*: $222.60
2019 Q1 (1 result)
Seth Klarman
+0.00%
+1
+0.00%
0.55%
Current price: $0.91 99.49% Reported price*: $177.30
2018 Q3 (1 result)
Seth Klarman
+237.55%
+253,789
+0.35%
0.49%
Current price: $0.91 99.47% Reported price*: $173.01
2018 Q2 (1 result)
Seth Klarman
buy
+79,594
+0.22%
0.16%
Current price: $0.91 99.60% Reported price*: $227.70
7 of 7

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.